ProShares Ultra CRCL
CRCA
7 hedge funds and large institutions have $4.48M invested in ProShares Ultra CRCL in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 12 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
135% more call options, than puts
Call options by funds: $5.05M | Put options by funds: $2.15M
2.11% less ownership
Funds ownership: 4.88% → 2.77% (-2.1%)
41% less capital invested
Capital invested by funds: $7.59M → $4.48M (-$3.11M)
59% less funds holding
Funds holding: 17 → 7 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.32M |
| 2 |
SG Americas Securities
New York
|
+$913K |
| 3 |
Morgan Stanley
New York
|
+$488K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$307K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$184K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.62M |
| 2 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$335K |
| 3 |
Optiver Holding
Amsterdam,
Netherlands
|
-$324K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$248K |
| 5 |
SG
StoneX Group
New York
|
-$243K |
CRCA Hedge Fund Activity: Q1 2026 in Review
7 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra CRCL (CRCA) for Q1 2026, worth a combined $4.48M — down 41% from $7.59M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CRCA and 2 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, adding an estimated $1.32M. The largest seller was Jane Street, exiting entirely with an estimated $4.62M sold.
- 7 institutional investors held ProShares Ultra CRCL (CRCA) as of Q1 2026, down from 17 in Q4 2025.
- Funds reported $4.48M of ProShares Ultra CRCL stock for Q1 2026, down 41% quarter-over-quarter.
- 2 funds opened new ProShares Ultra CRCL positions in Q1 2026 and 12 closed out, a net change of -10 holders.
- The largest ProShares Ultra CRCL buyer in Q1 2026 was Citadel Advisors, an estimated $1.32M added.
- The largest ProShares Ultra CRCL seller in Q1 2026 was Jane Street, an estimated $4.62M sold.
Based on aggregated 13F filings for Q1 2026.